Pragmatic Trials.
By Ian Ford, J. Norrie. New England Journal of Medicine, 2016
1,170 citations recorded by the source corpus.
Subfields: Economics and Econometrics, Public Health, Environmental and Occupational Health
View Paper: https://www.semanticscholar.org/paper/9c95d0f4b8505969428e3a04b7d212b327f01df9
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Economics and Econometrics
- Michael R. Kosorok
- Gary S. Collins
- Karel G. M. Moons
- Eric B. Laber
- John P. A. Ioannidis
- Irina Degtiar
- Sherri Rose
- Douglas G. Altman
In Public Health, Environmental and Occupational Health
Citations in the corpus
- Machine learning and artificial intelligence research for patient benefit: 20 critical questions on transparency, replicability, ethics, and effectiveness (2020, background): “79 Early consideration of what the potential pitfalls are of the proposed ML/AL based solution and how it could be manipulated (among other issues) would help researchers develop a better informed framework with which to decide how their tool should be built.”
- Precision Medicine. (2019, background): “A pragmatic clinical trial (see, e.g., (Ford and Norrie 2016)) is one in which various design features are carefully incorporated to ensure similarity with treatment conditions to the real world.”
- A Review of Generalizability and Transportability (2021, background): “…and Mullainathan, 2012); pragmatic or practical clinical trials, which aim to be representative of clinical practice (Schwartz and Lellouch, 1967; Ford and Norrie, 2016); stratified selection based on effect modifiers or propensity scores for selection (Tipton et al., 2014; Tipton, 2013a;…”
- 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. (2017, methodology): “An opportunity is the implementation of pragmatic clinical trials including registry-based randomized clinical trials.(477) These trials are less selective and less expensive alternatives to classical ones, especially for therapies used in clinical practice.”